Consolidated Balance Sheet

Oncolys BioPharma Inc. - Filing #7712870

Concept As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2017-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
811,997,000 JPY
454,508,000 JPY
Investments and other assets
809,740,000 JPY
452,002,000 JPY
Investment securities
668,201,000 JPY
400,194,000 JPY
Investments in capital
100,000 JPY
100,000 JPY
Long-term prepaid expenses
865,000 JPY
1,223,000 JPY
Other
19,000 JPY
19,000 JPY
Current assets
Cash and deposits
2,463,138,000 JPY
2,867,512,000 JPY
Accounts receivable - other
27,843,000 JPY
6,822,000 JPY
Accounts receivable - trade
50,063,000 JPY
88,736,000 JPY
Work in process
JPY
4,931,000 JPY
Prepaid expenses
29,438,000 JPY
51,011,000 JPY
Supplies
1,941,000 JPY
1,842,000 JPY
Other
726,000 JPY
285,000 JPY
Current assets
2,618,115,000 JPY
3,071,713,000 JPY
Non-current assets
Property, plant and equipment
Buildings, net
JPY
JPY
Property, plant and equipment
2,256,000 JPY
2,506,000 JPY
Investments and other assets
Assets
3,430,112,000 JPY
3,526,222,000 JPY
Liabilities
Current liabilities
Short-term borrowings
83,336,000 JPY
93,336,000 JPY
Deposits received
4,402,000 JPY
3,351,000 JPY
Accounts payable - other
71,012,000 JPY
88,740,000 JPY
Income taxes payable
35,933,000 JPY
32,826,000 JPY
Lease liabilities
5,795,000 JPY
9,822,000 JPY
Accrued expenses
11,845,000 JPY
10,959,000 JPY
Current liabilities
212,324,000 JPY
239,035,000 JPY
Non-current liabilities
Long-term borrowings
311,104,000 JPY
344,440,000 JPY
Lease liabilities
1,345,000 JPY
7,140,000 JPY
Non-current liabilities
316,634,000 JPY
355,293,000 JPY
Liabilities
528,959,000 JPY
594,328,000 JPY
Liabilities and net assets
Shareholders' equity
2,903,953,000 JPY
2,937,371,000 JPY
Share capital
6,402,658,000 JPY
5,802,444,000 JPY
Capital surplus
6,395,158,000 JPY
5,794,944,000 JPY
Retained earnings
-9,893,863,000 JPY
-8,660,016,000 JPY
Valuation and translation adjustments
-13,108,000 JPY
-15,786,000 JPY
Valuation difference on available-for-sale securities
-13,108,000 JPY
-15,786,000 JPY
Share acquisition rights
10,309,000 JPY
10,309,000 JPY
Net assets
-9,893,863,000 JPY
-9,893,863,000 JPY
-13,108,000 JPY
-13,108,000 JPY
6,395,158,000 JPY
10,309,000 JPY
2,901,153,000 JPY
6,402,658,000 JPY
6,395,158,000 JPY
2,903,953,000 JPY
-15,786,000 JPY
10,309,000 JPY
5,794,944,000 JPY
5,794,944,000 JPY
2,937,371,000 JPY
2,931,893,000 JPY
-15,786,000 JPY
-8,660,016,000 JPY
5,802,444,000 JPY
-8,660,016,000 JPY
2,605,149,000 JPY
-8,370,000 JPY
-7,569,313,000 JPY
5,090,981,000 JPY
-7,569,313,000 JPY
2,617,383,000 JPY
-8,370,000 JPY
5,083,481,000 JPY
20,604,000 JPY
5,083,481,000 JPY
Liabilities and net assets
3,430,112,000 JPY
3,526,222,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments

Talk to a Data Expert

Have a question? We'll get back to you promptly.